CN110887818B - Analysis method of blood sample, blood cell analyzer and storage medium - Google Patents
Analysis method of blood sample, blood cell analyzer and storage medium Download PDFInfo
- Publication number
- CN110887818B CN110887818B CN201811045480.8A CN201811045480A CN110887818B CN 110887818 B CN110887818 B CN 110887818B CN 201811045480 A CN201811045480 A CN 201811045480A CN 110887818 B CN110887818 B CN 110887818B
- Authority
- CN
- China
- Prior art keywords
- signal information
- blood cell
- blood sample
- red blood
- fluorescent signal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1434—Optical arrangements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1006—Investigating individual particles for cytology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1486—Counting the particles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Dispersion Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Description
技术领域technical field
本发明涉及样本分析领域,具体涉及一种血液样本的分析方法和血液细胞分析仪及存储介质。The invention relates to the field of sample analysis, in particular to a blood sample analysis method, a blood cell analyzer and a storage medium.
背景技术Background technique
血液细胞分析仪是一种可检测血液中细胞的一种仪器,例如可以对血液中的白细胞、红细胞、血小板、有核红细胞、网织红细胞等细胞进行分类和计数。A blood cell analyzer is an instrument that can detect cells in blood, for example, it can classify and count white blood cells, red blood cells, platelets, nucleated red blood cells, reticulocytes and other cells in blood.
以白细胞检测为例,最常见的一种方法为激光散射法,即血液细胞分析仪使用散射光对白细胞进行分类和计数。散射光包括前向散射光、侧向散射光、荧光信号等三种光信号。一般地,前向散射光可以反映细胞的大小信息,侧向散射光可以反映细胞内部结构的复杂程度,而荧光信号可以反映细胞内DNA、RNA等可被荧光染料染色物质的含量。利用这些光信号可对白细胞进行分类,同时可以得到白细胞的计数值。Taking white blood cell detection as an example, the most common method is the laser light scattering method, that is, blood cell analyzers use scattered light to classify and count white blood cells. Scattered light includes three types of light signals: forward scattered light, side scattered light, and fluorescent signal. Generally, the forward scattered light can reflect the size information of the cell, the side scattered light can reflect the complexity of the internal structure of the cell, and the fluorescent signal can reflect the content of intracellular DNA, RNA and other substances that can be dyed by fluorescent dyes. The white blood cells can be classified by using these light signals, and the count value of the white blood cells can be obtained at the same time.
应用现有的白细胞分类计数方法做一些血液检测时,准确性还不能满足要求。因此,需要开发准确性更好的白细胞分类方法。When applying the existing white blood cell differential counting method to do some blood tests, the accuracy can not meet the requirements. Therefore, it is necessary to develop a leukocyte classification method with better accuracy.
发明内容Contents of the invention
本申请提供一种血液样本的分析方法、血液细胞分析仪和存储介质。The application provides an analysis method of a blood sample, a blood cell analyzer and a storage medium.
提供一种血液样本的分析方法,包括:An analysis method for a blood sample is provided, comprising:
获取经荧光试剂处理后的血液样本荧光信号信息;Obtain the fluorescence signal information of the blood sample treated with the fluorescent reagent;
获取已测量的所述血液样本中的红细胞参数;obtaining the measured red blood cell parameters in the blood sample;
根据所述红细胞参数对所述荧光信号信息进行修正和/或发出荧光信号信息异常提示。The fluorescent signal information is corrected according to the red blood cell parameters and/or an abnormality prompt is issued for the fluorescent signal information.
在其中一个实施例中,所述获取经荧光试剂处理后的血液样本的荧光信号信息包括:获取经荧光试剂处理后的血液样本的荧光信号信息,以及前向散射光信号信息和/或侧向散射光信号信息。In one of the embodiments, the acquiring the fluorescent signal information of the blood sample treated with the fluorescent reagent includes: acquiring the fluorescent signal information of the blood sample treated with the fluorescent reagent, and the forward scattered light signal information and/or the lateral Scattered light signal information.
在其中一个实施例中,所述获取经荧光试剂处理后的血液样本的荧光信号信息包括:采用流式细胞术对所述血液样本进行测量以获取经荧光试剂处理后的血液样本的荧光信号信息,以及前向散射光信号信息和/或侧向散射光信号信息。In one of the embodiments, the acquiring the fluorescent signal information of the blood sample treated with the fluorescent reagent comprises: measuring the blood sample by flow cytometry to acquire the fluorescent signal information of the blood sample treated with the fluorescent reagent , and forward scattered light signal information and/or side scattered light signal information.
在其中一个实施例中,还包括:根据所述血液样本的侧向散射光值和修正后的荧光信号信息进行白细胞分类和/或计数。In one embodiment, further comprising: performing white blood cell classification and/or counting according to the side scattered light value of the blood sample and the corrected fluorescent signal information.
在其中一个实施例中,还包括:根据所述血液样本的前向散射光值和修正后的荧光信号信息进行有核红细胞计数。In one of the embodiments, the method further includes: counting nucleated red blood cells according to the forward scattered light value of the blood sample and the corrected fluorescent signal information.
在其中一个实施例中,还包括:根据所述血液样本的前向散射光值和修正后的荧光信号信息进行白细胞计数和/或网织红细胞识别和/或嗜碱性粒细胞分类。In one embodiment, further comprising: performing white blood cell count and/or reticulocyte identification and/or basophil classification according to the forward scattered light value of the blood sample and the corrected fluorescent signal information.
在其中一个实施例中,还包括:根据所述血液样本的侧向散射光值和修正后的荧光信号信息进行嗜碱性粒细胞分类。In one of the embodiments, the method further includes: classifying basophils according to the side scattered light value of the blood sample and the corrected fluorescence signal information.
在其中一个实施例中,获取经荧光试剂处理后的血液样本的荧光信号信息之前,还包括:对所述血液样本进行红细胞参数测量以确定所述红细胞参数,然后对所述血液样本进行溶血处理和荧光试剂处理,并测量所述血液样本的荧光信号信息。In one of the embodiments, before obtaining the fluorescence signal information of the blood sample treated with the fluorescent reagent, it also includes: performing red blood cell parameter measurement on the blood sample to determine the red blood cell parameter, and then performing hemolysis on the blood sample and fluorescent reagents, and measure the fluorescent signal information of the blood sample.
在其中一个实施例中,所述对所述血液样本进行红细胞参数测量以确定所述红细胞参数,包括:采用小孔阻抗法或光学法对所述血液样本进行红细胞参数测量以确定所述红细胞参数。In one embodiment, the measuring the red blood cell parameters of the blood sample to determine the red blood cell parameters includes: measuring the red blood cell parameters of the blood sample by using a small hole impedance method or an optical method to determine the red blood cell parameters .
在其中一个实施例中,所述根据所述红细胞参数对所述荧光信号信息进行修正包括:将所述红细胞参数和所述荧光信号信息作为自变量代入预设的修正函数,以得到作为因变量的修正后的荧光信号信息。In one embodiment, the correcting the fluorescent signal information according to the red blood cell parameters includes: substituting the red blood cell parameters and the fluorescent signal information as independent variables into a preset correction function to obtain The corrected fluorescent signal information.
在其中一个实施例中,所述修正函数为因变量相对于自变量的增函数。In one of the embodiments, the correction function is an increasing function of the dependent variable relative to the independent variable.
在其中一个实施例中,所述修正函数为一次函数、多项式函数或幂函数。In one of the embodiments, the correction function is a linear function, a polynomial function or a power function.
在其中一个实施例中,所述红细胞参数包括红细胞压积、红细胞计数和血红蛋白浓度中至少一种。In one of the embodiments, the red blood cell parameters include at least one of hematocrit, red blood cell count and hemoglobin concentration.
在其中一个实施例中,根据所述红细胞参数对所述荧光信号信息进行修正之后,还包括:输出经过修正后的荧光信号信息。In one of the embodiments, after correcting the fluorescent signal information according to the red blood cell parameters, the method further includes: outputting the corrected fluorescent signal information.
在其中一个实施例中,根据所述红细胞参数对所述荧光信号信息进行修正之后,还包括:输出经过修正前和修正后的荧光信号信息。In one of the embodiments, after correcting the fluorescent signal information according to the red blood cell parameters, the method further includes: outputting the fluorescent signal information before and after correction.
在其中一个实施例中,根据所述红细胞参数对所述荧光信号信息进行修正之后,还包括:发出荧光信号信息已经过修正的提示或发出报警。In one of the embodiments, after correcting the fluorescent signal information according to the red blood cell parameters, it further includes: issuing a prompt or issuing an alarm that the fluorescent signal information has been corrected.
在其中一个实施例中,所述发出荧光信号信息已经过修正的提示,包括:输出荧光信号信息的修正幅度。In one of the embodiments, the prompting that the fluorescent signal information has been corrected includes: outputting a correction range of the fluorescent signal information.
在其中一个实施例中,根据所述红细胞参数对所述荧光信号信息进行修正之后,还包括:如果荧光信号信息的修正幅度超过设定的阈值,则发出荧光信号信息已经过修正的提示或发出报警。In one of the embodiments, after correcting the fluorescent signal information according to the red blood cell parameters, it further includes: if the correction range of the fluorescent signal information exceeds the set threshold, sending a prompt or issuing a message that the fluorescent signal information has been corrected. Call the police.
还提供一种血液细胞分析仪,包括:Also provided is a hematology analyzer comprising:
至少一个反应池,用于为血液样本与试剂提供反应场所;At least one reaction pool is used to provide a reaction place for blood samples and reagents;
光学检测装置,用于对经试剂处理后的血液样本进行光照射,收集所述经试剂处理后的血液样本中各粒子因光照射所产生的光学信号,并转换成电信号,以输出光学信号信息;The optical detection device is used to irradiate the blood sample treated with the reagent with light, collect the optical signal generated by each particle in the blood sample treated with the reagent due to the light irradiation, and convert it into an electrical signal to output the optical signal information;
输送装置,用于将所述反应池中经试剂处理后的血液样本输送到所述光学检测装置中;A delivery device, used to deliver the reagent-treated blood sample in the reaction cell to the optical detection device;
处理器,用于接收并处理所述光学检测装置输出的光学信号信息,以得到血液样本的测量参数;其中,所述处理器获取经荧光试剂处理后的血液样本的荧光信号信息,获取已测量的所述血液样本中的红细胞参数,根据所述红细胞参数对所述荧光信号信息进行修正和/或发出荧光信号信息异常提示。a processor, configured to receive and process the optical signal information output by the optical detection device to obtain the measurement parameters of the blood sample; Red blood cell parameters in the blood sample, correcting the fluorescent signal information according to the red blood cell parameters and/or sending out abnormal fluorescent signal information prompts.
在其中一个实施例中,所述处理器获取经荧光试剂处理后的血液样本的荧光信号信息,以及白细胞粒子的前向散射光信号信息和/或侧向散射光信号信息。In one of the embodiments, the processor acquires the fluorescent signal information of the blood sample treated with the fluorescent reagent, and the forward scattered light signal information and/or the side scattered light signal information of the white blood cell particles.
在其中一个实施例中,所述光学检测装置包括光源和具有孔口的流动室,所述经荧光试剂处理后的血液样本中的白细胞粒子在所述流动室内流动,并逐个经过所述孔口,所述光源发出的光照射到所述孔口中的粒子并对应产生荧光信号和散射光信号,并经过所述光学检测装置的转换后向所述处理器输出荧光信号信息,以及前向散射光信号信息和/或侧向散射光信号信息。In one of the embodiments, the optical detection device includes a light source and a flow chamber with an orifice, and the leukocyte particles in the blood sample treated with the fluorescent reagent flow in the flow chamber and pass through the orifice one by one , the light emitted by the light source irradiates the particles in the orifice and correspondingly generates a fluorescent signal and a scattered light signal, and after being converted by the optical detection device, the fluorescent signal information and the forward scattered light are output to the processor signal information and/or side scattered light signal information.
在其中一个实施例中,所述处理器还根据所述血液样本的侧向散射光值和修正后的荧光信号信息进行白细胞分类和/或计数。In one of the embodiments, the processor further classifies and/or counts white blood cells according to the side scattered light value of the blood sample and the corrected fluorescent signal information.
在其中一个实施例中,所述处理器还根据所述血液样本的前向散射光值和修正后的荧光信号信息进行有核红细胞计数。In one of the embodiments, the processor also counts nucleated red blood cells according to the forward scattered light value of the blood sample and the corrected fluorescent signal information.
在其中一个实施例中,所述处理器还根据所述血液样本的前向散射光值和修正后的荧光信号信息进行白细胞计数和/或网织红细胞识别和/或嗜碱性粒细胞分类。In one of the embodiments, the processor further performs white blood cell count and/or reticulocyte identification and/or basophil classification according to the forward scattered light value of the blood sample and the corrected fluorescent signal information.
在其中一个实施例中,所述处理器还根据所述血液样本的侧向散射光值和修正后的荧光信号信息进行嗜碱性粒细胞分类。In one of the embodiments, the processor further classifies basophils according to the side scattered light value of the blood sample and the corrected fluorescence signal information.
在其中一个实施例中,所述反应池为所述血液样本与其进行红细胞参数测量所需试剂提供反应场所,所述光学检测装置对经过所述试剂处理后的血液样本进行红细胞参数测量,并输出光学信号信息,所述处理器根据该光学信号信息确定所述红细胞参数;所述反应池对所述血液样本进行溶血处理和荧光试剂处理,然后所述光学检测装置对处理后的血液样本进行测量,输出所述血液样本荧光信号信息。In one of the embodiments, the reaction pool provides a reaction place for the blood sample and the reagents required for the measurement of red blood cell parameters, and the optical detection device measures the red blood cell parameters of the blood sample processed by the reagents, and outputs Optical signal information, the processor determines the red blood cell parameters according to the optical signal information; the reaction pool performs hemolysis treatment and fluorescent reagent treatment on the blood sample, and then the optical detection device measures the processed blood sample , outputting the fluorescence signal information of the blood sample.
在其中一个实施例中,所述处理器用于:将所述红细胞参数和所述荧光信号信息作为自变量代入预设的修正函数,以得到作为因变量的修正后的荧光信号信息。In one embodiment, the processor is configured to: substitute the red blood cell parameters and the fluorescent signal information as independent variables into a preset correction function, so as to obtain corrected fluorescent signal information as a dependent variable.
在其中一个实施例中,所述修正函数为因变量相对于自变量的增函数。In one of the embodiments, the correction function is an increasing function of the dependent variable relative to the independent variable.
在其中一个实施例中,所述红细胞参数包括红细胞压积、红细胞计数和血红蛋白浓度中至少一种。In one of the embodiments, the red blood cell parameters include at least one of hematocrit, red blood cell count and hemoglobin concentration.
在其中一个实施例中,所述处理器还输出经过修正后的荧光信号信息。In one of the embodiments, the processor also outputs the corrected fluorescent signal information.
一种计算机可读存储介质,存储有程序,所述程序能够被处理器执行以实现如上述任一项实施例中所述的方法。A computer-readable storage medium stores a program, and the program can be executed by a processor to implement the method described in any one of the above embodiments.
依据上述实施例的血液样本的分析方法、血液细胞分析仪和计算机可读存储介质,使用红细胞参数对荧光信号信息进行修正,提高了荧光信号信息的准确性。According to the blood sample analysis method, the blood cell analyzer and the computer-readable storage medium of the above-mentioned embodiments, the red blood cell parameters are used to correct the fluorescent signal information, thereby improving the accuracy of the fluorescent signal information.
附图说明Description of drawings
图1为一种实施例的血液细胞分析仪的结构示意图;Fig. 1 is a schematic structural diagram of a blood cell analyzer of an embodiment;
图2为一种实施例的血液样本的分析方法的流程图;Fig. 2 is a flowchart of an analysis method of a blood sample in an embodiment;
图3为另一种实施例的血液样本的分析方法的流程图;Fig. 3 is a flow chart of another embodiment of a blood sample analysis method;
图4为再一种实施例的血液样本的分析方法的流程图;Fig. 4 is a flowchart of a blood sample analysis method in another embodiment;
图5为一种实施例的血液样本的荧光信号信息修正装置的结构示意图;Fig. 5 is a schematic structural diagram of a device for correcting fluorescence signal information of a blood sample according to an embodiment;
图6为统计多个样本中WBC粒子团在荧光方向上的位置值与HCT的散点图;Fig. 6 is a scatter diagram of the position value and HCT of the WBC particle cluster in the fluorescence direction in statistics of multiple samples;
图7为统计多个样本中WBC粒子团在荧光方向上的位置值与RBC的散点图;Fig. 7 is a scatter diagram of the position value of the WBC particle cluster in the fluorescence direction and the RBC in the statistics of multiple samples;
图8为统计多个样本中WBC粒子团在荧光方向上的位置值与HGB的散点图;Figure 8 is a scatter diagram of the position value of the WBC particle cluster in the fluorescence direction and the HGB in the statistics of multiple samples;
图9为一种实施例的使用HCT进行修正的第一函数的函数图;FIG. 9 is a function diagram of a first function corrected using HCT in an embodiment;
图10为三个样本中修正前和修正后的细胞粒子的荧光信号信息的示意图。Fig. 10 is a schematic diagram of fluorescence signal information of cell particles before and after correction in three samples.
具体实施方式Detailed ways
下面通过具体实施方式结合附图对本发明作进一步详细说明。其中不同实施方式中类似元件采用了相关联的类似的元件标号。在以下的实施方式中,很多细节描述是为了使得本申请能被更好的理解。然而,本领域技术人员可以毫不费力的认识到,其中部分特征在不同情况下是可以省略的,或者可以由其他元件、材料、方法所替代。在某些情况下,本申请相关的一些操作并没有在说明书中显示或者描述,这是为了避免本申请的核心部分被过多的描述所淹没,而对于本领域技术人员而言,详细描述这些相关操作并不是必要的,他们根据说明书中的描述以及本领域的一般技术知识即可完整了解相关操作。The present invention will be further described in detail below through specific embodiments in conjunction with the accompanying drawings. Wherein, similar elements in different implementations adopt associated similar element numbers. In the following implementation manners, many details are described for better understanding of the present application. However, those skilled in the art can readily recognize that some of the features can be omitted in different situations, or can be replaced by other elements, materials, and methods. In some cases, some operations related to the application are not shown or described in the description, this is to avoid the core part of the application being overwhelmed by too many descriptions, and for those skilled in the art, it is necessary to describe these operations in detail Relevant operations are not necessary, and they can fully understand the relevant operations according to the description in the specification and general technical knowledge in the field.
另外,说明书中所描述的特点、操作或者特征可以以任意适当的方式结合形成各种实施方式。同时,方法描述中的各步骤或者动作也可以按照本领域技术人员所能显而易见的方式进行顺序调换或调整。因此,说明书和附图中的各种顺序只是为了清楚描述某一个实施例,并不意味着是必须的顺序,除非另有说明其中某个顺序是必须遵循的。In addition, the characteristics, operations or characteristics described in the specification can be combined in any appropriate manner to form various embodiments. At the same time, the steps or actions in the method description can also be exchanged or adjusted in a manner obvious to those skilled in the art. Therefore, various sequences in the specification and drawings are only for clearly describing a certain embodiment, and do not mean a necessary sequence, unless otherwise stated that a certain sequence must be followed.
本文中为部件所编序号本身,例如“第一”、“第二”等,仅用于区分所描述的对象,不具有任何顺序或技术含义。而本申请所说“连接”、“联接”,如无特别说明,均包括直接和间接连接(联接)。The serial numbers assigned to components in this document, such as "first", "second", etc., are only used to distinguish the described objects, and do not have any sequence or technical meaning. The "connection" and "connection" mentioned in this application all include direct and indirect connection (connection) unless otherwise specified.
以常见的五分类血液细胞分析仪为例,设备一般会具有需要荧光信号测量的通道,其采用前向散射光、侧向散射光、荧光信号等三种散射光信号进行细胞分类和计数,例如可以进行白细胞计数,有核红细胞分类,有的还可以进行嗜碱性细胞的分类。Taking the common five-differentiation blood cell analyzer as an example, the equipment generally has a channel that requires fluorescence signal measurement. It uses three kinds of scattered light signals, such as forward scattered light, side scattered light, and fluorescent signal, to classify and count cells, for example White blood cell count, nucleated red blood cell classification, and some basophil classification can be performed.
先对本申请的一些英文名词进行说明。Some English nouns in this application are explained first.
RBC:红细胞(数量);RBC: red blood cells (number);
NRBC:有核红细胞(数量);NRBC: nucleated red blood cells (number);
RET:网织红细胞(数量);RET: reticulocytes (number);
HGB:红细胞血红蛋白含量;HGB: red blood cell hemoglobin content;
HCT:红细胞压积;HCT: hematocrit;
MCV:平均红细胞体积;MCV: mean corpuscular volume;
WBC:白细胞(数量);WBC: white blood cells (number);
BASO:嗜碱性粒细胞(数量)。BASO: Basophils (number).
常见的五分类血液细胞分析仪中会有需要荧光信号测量的通道,其采用前向散射光、侧向散射光、侧向荧光信号等三种光信号进行细胞分类和计数,例如可以进行白细胞计数,有核红细胞分类,有的还可以进行嗜碱性粒细胞的分类。本文说的通道,是指对某一类型细胞进行识别和/或计数和/或分类的检测通道,例如NRBC通道是用于计数有核红细胞的通道,WNB通道是用于分类有核红细胞的通道,RET通道是用于分类和/或计数网织红细胞的通道,DIFF通道是用于分类和/或计数白细胞的通道,BASO通道是用于计数嗜碱性粒细胞的通道,是本领域技术人员可以知晓的,在此不一一赘述。Common five-differentiation hematology analyzers have channels that require fluorescent signal measurement, which use three optical signals, including forward scattered light, side scattered light, and side fluorescent signal, to classify and count cells, for example, white blood cell counts can be performed , Classification of nucleated red blood cells, and some can also classify basophils. The channel mentioned in this article refers to the detection channel for identifying and/or counting and/or classifying a certain type of cells. For example, the NRBC channel is a channel for counting nucleated red blood cells, and the WNB channel is a channel for classifying nucleated red blood cells. , the RET channel is a channel for classifying and/or counting reticulocytes, the DIFF channel is a channel for classifying and/or counting white blood cells, and the BASO channel is a channel for counting basophils. What can be known will not be repeated here.
通过获取细胞的光信号来进行分类和计数,当不同样本的WBC粒子团出现不同位置时分类便会出现错误。在白细胞分类中,申请人通过长期研发发现,在一些样本下,当使用荧光染料处理细胞,利用荧光信号和散射光信号对细胞进行分类时,会出现测量结果与镜检的结果有偏差的情况。通过深入的研究发现,这类样本中,红细胞的参数与正常值不同。通过验证发现,红细胞参数与荧光信号强度存在一定的相关性,可以利用红细胞参数来修正荧光信号。虽然不受理论约束,本申请人推测可能红细胞会影响其他需要分类细胞的染色行为,导致荧光信号异常。Classification and counting are carried out by obtaining the optical signal of the cells, and when the WBC particle clusters of different samples appear in different positions, the classification will be wrong. In the classification of white blood cells, the applicant has discovered through long-term research and development that, in some samples, when the cells are treated with fluorescent dyes and the cells are classified using fluorescent signals and scattered light signals, there will be deviations between the measurement results and the results of microscopic examination . Through in-depth research, it was found that in such samples, the parameters of red blood cells were different from normal values. Through verification, it is found that there is a certain correlation between the red blood cell parameters and the intensity of the fluorescent signal, and the red blood cell parameters can be used to correct the fluorescent signal. While not being bound by theory, the applicant speculates that red blood cells may affect the staining behavior of other cells that need to be sorted, resulting in abnormal fluorescent signals.
申请人在实践中发现,当前较为常见的五分类血液细胞分析仪中,不妨以NRBC通道为例,其采用荧光染料对细胞进行染色处理时,不同样本在荧光方向上细胞荧光信号的位置会出现差异,而在计数分类细胞(例如白细胞)过程中,荧光信号过大或过小,都会对计数、分类设门白细胞算法造成影响(例如荧光信号影响设门),这会影响NRBC通道的计数和分类,进一步还会导致临床误诊断风险增大。不妨再以RET通道为例,其测试过程中会由于不同分布的红细胞造成荧光染料对细胞的处理程度不同,从而造成荧光方向上细胞的信号不同,从而对分类红细胞例如识别RET造成影响。The applicant found in practice that in the currently common five-differentiation blood cell analyzer, we might as well take the NRBC channel as an example. When the cells are stained with fluorescent dyes, the positions of the cell fluorescence signals in the fluorescence direction of different samples will appear. In the process of counting and classifying cells (such as white blood cells), if the fluorescent signal is too large or too small, it will affect the algorithm of counting and classifying white blood cells (for example, the fluorescent signal affects the setting of the gate), which will affect the counting and counting of NRBC channels. Classification will further increase the risk of clinical misdiagnosis. Let’s take the RET channel again as an example. During the testing process, different distributions of red blood cells will result in different processing degrees of fluorescent dyes on the cells, resulting in different signals of cells in the direction of fluorescence, which will affect the classification of red blood cells such as the recognition of RET.
因此,对于那些采用荧光染料的通道——例如NRBC通道、RET通道和DIFF通道等,当这些通道进行样本测量时,如果不进行荧光信号修正,WBC粒子的荧光信号会出现过大或过小,在信号采集器字节位数有限的情况下,由于信号会有最大和最小的限制,最终会出现WBC粒子团在散点图中过于靠左或靠右的情况,从而导致通道散点图失真,缺失必要的散点图信息,给后续分类造成困难,很容易出现血影、有核红细胞、嗜碱性粒细胞的分类错误,从而给出错误的计数和分类结果。Therefore, for those channels that use fluorescent dyes, such as NRBC channels, RET channels, and DIFF channels, when these channels are used for sample measurement, if the fluorescence signal correction is not performed, the fluorescence signal of WBC particles will appear too large or too small, In the case of a limited number of bytes in the signal collector, due to the maximum and minimum limits of the signal, the WBC particle cluster will eventually appear too far to the left or right in the scatter diagram, resulting in distortion of the channel scatter diagram , the lack of necessary scattergram information makes it difficult for subsequent classification, and it is easy to make mistakes in the classification of blood ghosts, nucleated red blood cells, and basophils, thus giving wrong counting and classification results.
综上所述,对有那些采用荧光染料的通道——例如NRBC通道、BASO通道、WNB通道、RET通道和DIFF通道等,需要一种修正不同样本在这些通道中荧光信号差异的技术方案。To sum up, for those channels using fluorescent dyes, such as NRBC channel, BASO channel, WNB channel, RET channel and DIFF channel, etc., there is a need for a technical solution to correct the difference in fluorescence signals of different samples in these channels.
申请人针对上述问题,经过试剂作用理论分析与大量样本研究后发明,对于采用荧光染料的通道——例如NRBC通道,实际测量过程中,其WBC粒子的荧光信号与红细胞计数(RBC)、红细胞血红蛋白含量(HGB)、红细胞压积(HCT)呈负相关的关系,即同一样本或者说血样,RBC、HGB、HCT越小,WBC粒子的荧光信号越大;RBC、HGB、HCT越大,WBC粒子荧光信号越小。因此可以利用RBC、HGB、HCT对WBC粒子的荧光信号进行修正和/或发出荧光信号信息异常提示,也即可以根据红细胞参数对荧光信号信息进行修正和/或发出荧光信号信息异常提示。可以仅仅修正,也可以仅仅发出异常提示,当然也可以既修正又发出异常提示。In response to the above problems, the applicant discovered after theoretical analysis of reagent action and research on a large number of samples that for channels using fluorescent dyes—for example, NRBC channels, during the actual measurement process, the fluorescent signal of its WBC particles is related to red blood cell count (RBC), erythrocyte hemoglobin Content (HGB) and hematocrit (HCT) are negatively correlated, that is, the same sample or blood sample, the smaller the RBC, HGB, and HCT, the larger the fluorescence signal of WBC particles; the larger the RBC, HGB, and HCT, the larger the WBC particle The fluorescent signal is smaller. Therefore, RBC, HGB, and HCT can be used to correct the fluorescent signal of WBC particles and/or send out abnormal fluorescent signal information, that is, the fluorescent signal information can be corrected according to red blood cell parameters and/or send out abnormal fluorescent signal information. It can only be corrected, or only an abnormal prompt can be issued, and of course, both correction and abnormal prompt can be issued.
实施例1Example 1
本发明一实施例的血液细胞分析仪可以主要包括如图1所示的结构:至少一个反应池101、光学检测装置102、输送装置103和处理器104,下面具体说明。A blood cell analyzer according to an embodiment of the present invention may mainly include the structure shown in FIG. 1 : at least one
反应池101用于为血液样本与试剂提供反应场所,以制备成样本液。具体地,可对采血所得血液样本经稀释并用荧光染色试剂进行标记,得到样本液。常用的荧光染色试剂可以是派若宁、吖啶橙和噻唑橙等。The
光学检测装置102用于对经试剂处理后的血液样本即上述的样本液进行光照射,收集所述经试剂处理后的血液样本中各粒子因光照射所产生的光学信号,并转换成电信号,以输出光学信号信息。这里的光学信号可以是前向散射光信号、侧向散射光信号、荧光信号。光学检测装置102的一个实施例中,其可以包括光源1021和具有孔口10221的鞘流流动室1022等,血液样本中的粒子可在鞘流流动室1022内流动,并逐个经过孔口10221,光源1021所发出的光可照射到孔口10221中的粒子并对应产生散射光信号和/或荧光信号。光学检测装置102还可以包括分别在孔口前方和侧向设置的透镜组1023、光电感应器1024(如光电二极管、光电倍增管等)及A/D转换器,A/D转换器可设置在处理器104中或单独形成一个元件,从而透镜组1023可捕捉对应散射光信号和荧光信号,光电感应器1024可将捕捉到的光学信号(指散射光信号和荧光信号等)转换为电信号,再A/D转换器将电信号经A/D转换处理得到数字信号,可以将该数字信号作为光学信号信息输出。The
输送装置103用于将反应池101中经试剂处理后的血液样本即样本液输送到光学检测装置102中。The
处理器104用于接收并处理光学检测装置102输出的光学信号信息,以得到血液样本的测量参数。处理器104的一个实施例中,其获取经荧光试剂处理后的血液样本荧光信号信息,获取已测量的所述血液样本中的红细胞参数,根据所述红细胞参数对所述荧光信号信息进行修正。荧光信号所表示的粒子主要为白细胞粒子或血影粒子,其中血影粒子是指红细胞经低渗处理后,质膜破裂剩下保持原来的形态和大小的细胞膜结构的粒子。一实施例中,所述红细胞参数包括红细胞压积、红细胞计数和血红蛋白浓度中至少一种。The
如上所述,处理器104获取的数据有血液样本的荧光信息号信息以及血液样本中的红细胞参数,在一实施例中,处理器104还可以获取所述血液样本的前向散射光信号信息或侧向散射光信号信息。这三类数据——即第一类数据:血液样本的荧光信息号信息,第二类数据:所述血液样本的前向散射光信号信息或侧向散射光信号信息,第三类数据:所述血液样本中的红细胞参数——的一项或多项可以由其他设备传输给本发明的血液细胞分析仪中的处理器,也可以由本发明的血液细胞分析仪测量来得到,下面进行举例说明。As mentioned above, the data acquired by the
处理器104对第一类数据(血液样本的荧光信息号信息)的获取:反应池101对血液样本进行溶血处理和荧光试剂处理,输送装置103将溶血处理和荧光试剂处理后的血液样本输送到光学检测装置102中,光学检测装置102对溶血处理和荧光试剂处理后的血液样本进行测量,输出所述血液样本的荧光信号信息给处理器104。Acquisition of the first type of data (fluorescent information number information of the blood sample) by the processor 104: the
处理器104对第二类数据(所述血液样本的前向散射光信号信息或侧向散射光信号信息)的获取:可以在获取荧光信号时,也获取前向散射光信号信息和侧向散射光信号信息;例如,反应池101对血液样本进行溶血处理和荧光试剂处理,输送装置103将溶血处理和荧光试剂处理后的血液样本输送到光学检测装置102中,光学检测装置102对溶血处理和荧光试剂处理后的血液样本进行测量,输出所述血液样本的荧光信号信息,前向散射光信号信息和侧向散射光信号信息中的一者或两者给处理器104。具体地,通过输送装置103的输送,经荧光试剂处理后的血液样本中的细胞粒子在鞘流流动室1022内流动,并逐个经过孔口10221,光源1021发出的光照射到孔口10221中的细胞粒子并对应产生细胞粒子的荧光信号和散射光信号(指前向散射光信号信息和侧向散射光信号信息中的一者或两者),并经过光学检测装置10221的转换后向处理器104输出荧光信号信息,以及前向散射光信号信息或侧向散射光信号信息。Acquisition of the second type of data (forward scattered light signal information or side scattered light signal information of the blood sample) by the processor 104: the forward scattered light signal information and the side scattered light signal information may also be obtained when obtaining the fluorescence signal Optical signal information; for example, the
处理器104通过获取的荧光信号信息和散色光信号信息,可以做以下的细胞检测。根据血液样本的侧向散射光值和修正后的荧光信号信息进行白细胞分类和/或计数,例如通过DIFF通道进行白细胞四分类。根据血液样本的前向散射光值和修正后的荧光信号信息进行有核红细胞计数,例如通过NRBC通道进行有核红细胞计数。根据血液样本的前向散射光值和修正后的荧光信号信息进行白细胞计数和/或网织红细胞识别和/或嗜碱性粒细胞分类,例如通过RET通道进行网织红细胞分类和/或计数。根据血液样本的侧向散射光值和修正后的荧光信号信息进行嗜碱性粒细胞分类,例如通过BASO通道进行嗜碱性粒细胞分类。The
处理器104对第三类数据(所述血液样本中的红细胞参数)的获取:反应池101为所述血液样本与其进行红细胞参数测量所需试剂提供反应场所,输送装置103将试剂处理后的血液样本输送到光学检测装置102中,光学检测装置102对经过试剂处理后的血液样本进行红细胞参数测量,并输出光学信号信息,处理器104根据该光学信号信息确定所述红细胞参数。即可以通过光学法检测获取血液样本中的红细胞参数。当然,在其他的实施例中,血液样本中的红细胞参数还可以是通过小孔阻抗法测量获取,例如从血液细胞分析仪本身的检测装置或其他仪器通过小孔阻抗法对血液样本进行测量。Acquisition of the third type of data (red blood cell parameters in the blood sample) by the processor 104: the
以上是处理器104对上述三类数据的获取的说明,下面对处理器104的修正进行说明。The above is the description of the acquisition of the above three types of data by the
一实施例中,处理器104根据所述红细胞参数对所述荧光信号信息进行修正,可以包括:根据所述红细胞参数对所述荧光信号信息进行增大修正和/或减少修正。修正的目标是:无论HCT、RBC、HGB这些红细胞参数如何变化,粒子对应的荧光信号值都被修正到粒子的正常荧光信号强度值附近。In an embodiment, the
(1)增大修正(1) Increase correction
处理器104根据所述红细胞参数对所述荧光信号信息进行增大修正,包括:如果所述红细胞参数大于第一预设值,则对所述荧光信号信息进行增大修正。进一步地,在一实施例中如果所述红细胞参数大于第一预设值,则所述红细胞参数越大,处理器104对所述荧光信号信息进行增大修正的幅度越大。第一预设值的设置,可以根据粒子正常荧光强度情况下的正常红细胞参数值作为参考。The
如上所述,红细胞参数可以包RBC、HGB和HCT中的至少一种。当红细胞参数只包括RBC、HGB和HCT中的一种时,那么红细胞参数大于第一预设值很好理解;当红细胞参数包括RBC、HGB和HCT中的二种或三种时,红细胞参数大于第一预设值可以指的是:将红细胞参数所包括的RBC、HGB和HCT中的二种或三种进行加权和,或者加权平均计算,具体的权重值可以在实际中灵活设置,计算得到的值作为红细胞参数来与第一预设值比较,当计算得到的值大于第一预设值时,就认为是红细胞参数大于第一预设值。例如,当红细胞参数包括RBC、HGB和HCT这三种时,计算RBC、HGB和HCT这三个参数进行加权和,或者加权平均计算,将计算得到的值视为红细胞参数的值来与第一预设值进行比较,当计算得到的值大于第一预设值,就表示红细胞参数大于第一预设值。As mentioned above, the red blood cell parameters may include at least one of RBC, HGB and HCT. When the red blood cell parameters only include one of RBC, HGB and HCT, it is well understood that the red blood cell parameters are greater than the first preset value; when the red blood cell parameters include two or three of RBC, HGB and HCT, the red blood cell parameters are greater than The first preset value may refer to: performing a weighted sum of two or three of RBC, HGB, and HCT included in the red blood cell parameters, or a weighted average calculation. The specific weight value can be flexibly set in practice, and the calculated The value of is used as the red blood cell parameter to compare with the first preset value, and when the calculated value is greater than the first preset value, it is considered that the red blood cell parameter is greater than the first preset value. For example, when the red blood cell parameters include RBC, HGB and HCT, the weighted sum of the three parameters of RBC, HGB and HCT is calculated, or the weighted average is calculated, and the calculated value is regarded as the value of the red blood cell parameter to be compared with the first The preset value is compared, and when the calculated value is greater than the first preset value, it means that the red blood cell parameter is greater than the first preset value.
(2)减少修正(2) Reduce correction
处理器104根据所述红细胞参数对所述荧光信号信息进行减少修正,包括:如果所述红细胞参数小于第一预设值,则对所述荧光信号信息进行减少修正。进一步地,在一实施例中如果所述红细胞参数小于第一预设值,则所述红细胞参数越小,处理器104对所述荧光信号信息进行减少修正的幅度越大The
如上所述,红细胞参数可以包RBC、HGB和HCT中的至少一种。当红细胞参数只包括RBC、HGB和HCT中的一种时,那么红细胞参数小于第一预设值很好理解;当红细胞参数包括RBC、HGB和HCT中的二种或三种时,红细胞参数小于第一预设值可以指的是:将红细胞参数所包括的RBC、HGB和HCT中的二种或三种进行加权和,或者加权平均计算,具体的权重值可以在实际中灵活设置,计算得到的值作为红细胞参数来与第一预设值比较,当计算得到的值小于第一预设值时,就认为是红细胞参数小于第一预设值。例如,当红细胞参数包括RBC、HGB和HCT这三种时,计算RBC、HGB和HCT这三个参数进行加权和,或者加权平均计算,将计算得到的值视为红细胞参数的值来与第一预设值进行比较,当计算得到的值小于第一预设值,就表示红细胞参数小于第一预设值。As mentioned above, the red blood cell parameters may include at least one of RBC, HGB and HCT. When the red blood cell parameters include only one of RBC, HGB and HCT, it is easy to understand that the red blood cell parameters are less than the first preset value; when the red blood cell parameters include two or three of RBC, HGB and HCT, the red blood cell parameters are less than The first preset value may refer to: performing a weighted sum of two or three of RBC, HGB, and HCT included in the red blood cell parameters, or a weighted average calculation. The specific weight value can be flexibly set in practice, and the calculated The value of is used as the red blood cell parameter to compare with the first preset value, and when the calculated value is smaller than the first preset value, it is considered that the red blood cell parameter is smaller than the first preset value. For example, when the red blood cell parameters include RBC, HGB and HCT, the weighted sum of the three parameters of RBC, HGB and HCT is calculated, or the weighted average is calculated, and the calculated value is regarded as the value of the red blood cell parameter to be compared with the first Compared with the preset value, when the calculated value is smaller than the first preset value, it means that the red blood cell parameter is smaller than the first preset value.
处理器104根据所述红细胞参数对所述荧光信号信息进行增大修正和/或减少修正,包括:将所述红细胞参数和所述荧光信号信息作为自变量代入预设的修正函数,以得到作为因变量的修正后的荧光信号信息,其中所述修正函数为因变量相对于自变量的增函数。The
在一实施例中,所述修正函数可以为一次函数或幂函数。在一实施例中,所述修正函数包括第一函数和第二函数,所述第一函数和第二函数均为增函数;所述处理器将所述红细胞参数和所述荧光信号信息作为自变量代入预设的修正函数包括:将所述红细胞参数作为自变量代入所述第一函数得到修正系数,将所述修正系数作为常量和将所述荧光信号信息作为自变量代入所述第二函数以得到作为因变量的修正后的荧光信号信息。处理器104的一个实施例中,还可以输出经过修正后的荧光信号信息,例如根据修正后的荧光信号信息通过显示器显示荧光信号散点图,或者将修正后的荧光信号信息发送给远端服务器、中央站。当然,在一些实施例中,还可以输出经过修正前和修正后的荧光信号信息,例如根据修正后的荧光信号信息通过显示器显示修正后的荧光信号散点图,并根据修正前的荧光信号信息通过显示器显示修正前的荧光信号散点图,以方便用户对比。In an embodiment, the correction function may be a linear function or a power function. In one embodiment, the correction function includes a first function and a second function, both of which are increasing functions; the processor uses the red blood cell parameters and the fluorescent signal information as an automatic Substituting variables into the preset correction function includes: substituting the red blood cell parameters as an independent variable into the first function to obtain a correction coefficient, using the correction coefficient as a constant and the fluorescent signal information as an independent variable into the second function In order to obtain the corrected fluorescent signal information as the dependent variable. In an embodiment of the
在一些实施例中,修正之后,处理器104还可以发出荧光信号信息已经过修正的提示或发出报警,例如通过显示器向用户发出提示。而在一些实施例中,处理器104还可以输出荧光信号信息的修正幅度,例如通过显示器以百分比的形式显示荧光信号信息的修正幅度。在一些实施例中,如果荧光信号信息的修正幅度超过设定的阈值,则才发出荧光信号信息已经过修正的提示或发出报警。In some embodiments, after correction, the
下面举例说明修正函数、第一函数和第二函数。The correction function, the first function, and the second function are illustrated below as examples.
下式(1)至(7)的公式中,yfl表示修正后的荧光信号信息,xfl表示修正前的荧光信号信息,x1、x2、x3分别表示HCT、RBC、HGB的值。In the following formulas (1) to (7), y fl represents the fluorescent signal information after correction, x fl represents the fluorescent signal information before correction, and x 1 , x 2 , and x 3 represent the values of HCT, RBC, and HGB, respectively .
(1)当所述红细胞参数只包括HCT时,修正函数可以有如下形式:(1) When the red blood cell parameters only include HCT, the correction function can have the following form:
yfl=f1(x1,xfl);y fl =f 1 (x 1 ,x fl );
进一步地,修正函数f1(x1,xfl)包括的第一函数可以为f11(x1),第二函数可以为f12(xfl),例如第二函数f12(xfl)=k1xfl+b,k1和b为常数,上述将所述修正系数作为常量代入第二函数,可以是指k1=f11(x1)。Further, the first function included in the correction function f 1 (x 1 , x fl ) may be f 11 (x 1 ), and the second function may be f 12 (x fl ), for example, the second function f 12 (x fl ) =k 1 x fl +b, k 1 and b are constants, and the above-mentioned substitution of the correction coefficient as a constant into the second function may refer to k 1 =f 11 (x 1 ).
(2)当所述红细胞参数只包括RBC时,修正函数可以有如下形式:(2) When the red blood cell parameters only include RBC, the correction function can have the following form:
yfl=f2(x2,xfl);y fl =f 2 (x 2 ,x fl );
进一步地,修正函数f2(x2,xfl)包括的第一函数可以为f21(x2),第二函数可以为f22(xfl),例如第二函数f22(xfl)=k2xfl+b,k2和b为常数,上述将所述修正系数作为常量代入第二函数,可以是指k2=f21(x2)。Further, the first function included in the correction function f 2 (x 2 , x fl ) may be f 21 (x 2 ), and the second function may be f 22 (x fl ), for example, the second function f 22 (x fl ) =k 2 x fl +b, k 2 and b are constants, and the above-mentioned substitution of the correction coefficient as a constant into the second function may refer to k 2 =f 21 (x 2 ).
(3)当所述红细胞参数只包括HGB时,修正函数可以有如下形式:(3) When the red blood cell parameters only include HGB, the correction function can have the following form:
yfl=f3(x3,xfl);y fl =f 3 (x 3 ,x fl );
进一步地,修正函数f3(x3,xfl)包括的第一函数可以为f31(x3),第二函数可以为f32(xfl),例如第二函数f32(xfl)=k3xfl+b,k3和b为常数,上述将所述修正系数作为常量代入第二函数,可以是指k3=f31(x3)。Further, the first function included in the correction function f 3 (x 3 , x fl ) may be f 31 (x 3 ), and the second function may be f 32 (x fl ), for example, the second function f 32 (x fl ) =k 3 x fl +b, k 3 and b are constants, and the above-mentioned substitution of the correction coefficient as a constant into the second function may refer to k 3 =f 31 (x 3 ).
(4)当所述红细胞参数包括HCT和RBC时,修正函数可以有如下形式:(4) When the red blood cell parameters include HCT and RBC, the correction function can have the following form:
yfl=f4(x1,x2,xfl);y fl =f 4 (x 1 ,x 2 ,x fl );
进一步地,修正函数f4(x1,x2,xfl)包括的第一函数可以为f41(x1,x2),第二函数可以为f42(xfl),例如第二函数f42(xfl)=k4xfl+b,k4和b为常数,上述将所述修正系数作为常量代入第二函数,可以是指k4=f41(x1,x2)。Further, the first function included in the correction function f 4 (x 1 , x 2 , x fl ) may be f 41 (x 1 , x 2 ), and the second function may be f 42 (x fl ), for example, the second function f 42 (x fl )=k 4 x fl +b, k 4 and b are constants, and the above-mentioned substitution of the correction coefficient as a constant into the second function may refer to k 4 =f 41 (x 1 ,x 2 ).
(5)当所述红细胞参数包括RBC和HGB时,修正函数可以有如下形式:(5) When the red blood cell parameters include RBC and HGB, the correction function can have the following form:
yfl=f5(x2,x3,xfl);y fl =f 5 (x 2 ,x 3 ,x fl );
进一步地,修正函数f5(x2,x3,xfl)包括的第一函数可以为f51(x2,x3),第二函数可以为f52(xfl),例如第二函数f52(xfl)=k5xfl+b,k5和b为常数,上述将所述修正系数作为常量代入第二函数,可以是指k5=f51(x2,x3)。Further, the first function included in the correction function f 5 (x 2 , x 3 , x fl ) may be f 51 (x 2 , x 3 ), and the second function may be f 52 (x fl ), for example, the second function f 52 (x fl )=k 5 x fl +b, k 5 and b are constants, and the above-mentioned substitution of the correction coefficient as a constant into the second function may refer to k 5 =f 51 (x 2 ,x 3 ).
(6)当所述红细胞参数包括HCT和HGB时,修正函数可以有如下形式:(6) When the red blood cell parameters include HCT and HGB, the correction function can have the following form:
yfl=f6(x1,x3,xfl);y fl =f 6 (x 1 ,x 3 ,x fl );
进一步地,修正函数f6(x1,x3,xfl)包括的第一函数可以为f61(x1,x3),第二函数可以为f62(xfl),例如第二函数f62(xfl)=k6xfl+b,k6和b为常数,上述将所述修正系数作为常量代入第二函数,可以是指k6=f61(x1,x3)。Further, the first function included in the correction function f 6 (x 1 , x 3 , x fl ) may be f 61 (x 1 , x 3 ), and the second function may be f 62 (x fl ), for example, the second function f 62 (x fl )=k 6 x fl +b, k 6 and b are constants, and the above-mentioned substitution of the correction coefficient as a constant into the second function may refer to k 6 =f 61 (x 1 ,x 3 ).
(7)当所述红细胞参数包括HCT、RBC和HGB时,修正函数可以有如下形式:(7) When the red blood cell parameters include HCT, RBC and HGB, the correction function can have the following form:
yfl=f7(x1,x2,x3,xfl);y fl =f 7 (x 1 ,x 2 ,x 3 ,x fl );
进一步地,修正函数f7(x1,x2,x3,xfl)包括的第一函数可以为f71(x1,x2,x3),第二函数可以为f72(xfl),例如第二函数f72(xfl)=k7xfl+b,k7和b为常数,上述将所述修正系数作为常量代入第二函数,可以是指k7=f71(x1,x2,x3)。Further, the first function included in the correction function f 7 (x 1 , x 2 , x 3 , x fl ) may be f 71 (x 1 , x 2 , x 3 ), and the second function may be f 72 (x fl ), for example, the second function f 72 (x fl )=k 7 x fl +b, k 7 and b are constants, and the above-mentioned substitution of the correction coefficient into the second function as a constant may refer to k 7 =f 71 (x 1 ,x 2 ,x 3 ).
实施例2Example 2
本发明一实施例中还提供一种血液样本的分析方法(以下简称分析方法)。请参照图2,分析方法可以包括步骤310~350。An embodiment of the present invention also provides a blood sample analysis method (hereinafter referred to as the analysis method). Referring to FIG. 2 , the analysis method may include steps 310 - 350 .
步骤310:获取经荧光试剂处理后的血液样本的荧光信号信息。在一实施例中,步骤310可以包括:获取经荧光试剂处理后的血液样本的荧光信号信息,以及前向散射光信号信息或侧向散射光信号信息。Step 310: Obtain fluorescence signal information of the blood sample treated with the fluorescent reagent. In an embodiment, step 310 may include: acquiring fluorescence signal information of the blood sample treated with the fluorescent reagent, and forward scattered light signal information or side scattered light signal information.
步骤330:获取已测量的所述血液样本中的红细胞参数。在一实施例中,所述红细胞参数包括红细胞压积、红细胞计数和血红蛋白浓度中至少一种。Step 330: Obtain the measured red blood cell parameters in the blood sample. In one embodiment, the red blood cell parameters include at least one of hematocrit, red blood cell count and hemoglobin concentration.
以上步骤中,步骤310获取的荧光信号信息、前向散射光信号信息和侧向散射光信号信息的这些数据,可以是实时测量的,也可以是非实时测量的,例如这些数据被存储在一存储器中,步骤310从该存储器来获取数据。类似地,步骤330获取的红细胞参数,可以是实时测量来获取的,也可以是非实时测量来获取的,例如所述血液样本中的红细胞参数被提前存储在一存储器,步骤330从该存储器中来获取所述血液样本中的红细胞参数。In the above steps, the data of fluorescence signal information, forward scattered light signal information and side scattered light signal information obtained in
不妨以实时测量获取血液样本的荧光信号信息和所述血液样本中的红细胞参数为例,请参照图3,分析方法的一个实施例中,还可以包括步骤300和步骤320,下面具体说明。Let’s take the real-time measurement of the fluorescence signal information of the blood sample and the red blood cell parameters in the blood sample as an example. Please refer to FIG. 3 . An embodiment of the analysis method may also include
步骤300:对所述血液样本进行溶血处理和荧光试剂处理,并测量所述血液样本的荧光信号信息。Step 300: Perform hemolysis treatment and fluorescent reagent treatment on the blood sample, and measure the fluorescent signal information of the blood sample.
步骤320:对所述血液样本进行红细胞参数测量以确定所述红细胞参数。在一实施例中,如果分析方法同时具有步骤300和步骤320,可以是先进行步骤320,然后再进行步骤300,例如对所述血液样本进行红细胞参数测量以确定所述红细胞参数,然后对所述血液样本进行溶血处理和荧光试剂处理,并测量所述血液样本的荧光信号信息。Step 320: Perform red blood cell parameter measurement on the blood sample to determine the red blood cell parameter. In one embodiment, if the analysis method has
不妨以实时测量获取血液样本的荧光信号信息、散色光信号信息(前向散射光信号信息或侧向散射光信号信息),分析方法的一个实施例中,步骤310可以是采用流式细胞术对所述血液样本进行测量以获取经荧光试剂处理后的血液样本的荧光信号信息,以及前向散射光信号信息或侧向散射光信号信息。It may be advisable to obtain the fluorescence signal information and scattered light signal information (forward scattered light signal information or side scattered light signal information) of the blood sample by real-time measurement. In an embodiment of the analysis method, step 310 may be to use flow cytometry to analyze The blood sample is measured to obtain the fluorescence signal information of the blood sample treated with the fluorescent reagent, and the forward scattered light signal information or the side scattered light signal information.
通过获取的荧光信号信息和散色光信号信息,可以做以下的细胞检测。根据血液样本的侧向散射光值和修正后的荧光信号信息进行白细胞分类和/或计数,例如通过DIFF通道进行白细胞四分类。根据血液样本的前向散射光值和修正后的荧光信号信息进行有核红细胞计数,例如通过NRBC通道进行有核红细胞计数。根据血液样本的前向散射光值和修正后的荧光信号信息进行白细胞计数和/或网织红细胞识别和/或嗜碱性粒细胞分类,例如通过RET通道进行网织红细胞分类和/或计数。根据血液样本的侧向散射光值和修正后的荧光信号信息进行嗜碱性粒细胞分类,例如通过BASO通道进行嗜碱性粒细胞分类。Through the obtained fluorescent signal information and scattered light signal information, the following cell detection can be performed. The white blood cell classification and/or counting is performed according to the side scattered light value of the blood sample and the corrected fluorescent signal information, for example, four classifications of the white blood cells are performed through the DIFF channel. Nucleated red blood cell count is performed according to the forward scattered light value of the blood sample and the corrected fluorescent signal information, for example, the nucleated red blood cell count is performed through the NRBC channel. Perform white blood cell count and/or reticulocyte identification and/or basophil classification according to the forward scattered light value of the blood sample and the corrected fluorescent signal information, for example, perform reticulocyte classification and/or count through the RET channel. Basophil classification is performed based on the side scatter light value of the blood sample and the corrected fluorescence signal information, such as basophil classification by the BASO channel.
步骤350:根据所述红细胞参数对所述荧光信号信息进行修正和/或发出荧光信号信息异常提示。也即可以根据红细胞参数对荧光信号信息进行修正和/或发出荧光信号信息异常提示。可以仅仅修正,也可以仅仅发出异常提示,当然也可以既修正又发出异常提示Step 350: Correcting the fluorescent signal information according to the red blood cell parameters and/or issuing a prompt for abnormal fluorescent signal information. That is, the fluorescent signal information can be corrected according to the red blood cell parameters and/or an abnormality prompt can be issued for the fluorescent signal information. It can only be corrected, or only an abnormal prompt can be issued, of course, it can also be corrected and an abnormal prompt can be issued
在一些实施例中,步骤350根据所述红细胞参数对所述荧光信号信息进行修正,包括:根据所述红细胞参数对所述荧光信号信息进行增大修正和/或减少修正。修正的目标是:无论HCT、RBC、HGB这些红细胞参数如何变化,粒子对应的荧光信号值都被修正到粒子的正常荧光信号强度值附近。In some embodiments, step 350 correcting the fluorescent signal information according to the red blood cell parameters includes: performing an increase correction and/or a decrease correction on the fluorescent signal information according to the red blood cell parameters. The goal of the correction is: no matter how the red blood cell parameters such as HCT, RBC, and HGB change, the fluorescent signal value corresponding to the particle is corrected to be close to the normal fluorescent signal intensity value of the particle.
(1)增大修正(1) Increase correction
步骤350根据所述红细胞参数对所述荧光信号信息进行增大修正,包括:如果所述红细胞参数大于第一预设值,则对所述荧光信号信息进行增大修正。进一步地,在一实施例中如果所述红细胞参数大于第一预设值,则所述红细胞参数越大,步骤350对所述荧光信号信息进行增大修正的幅度越大。第一预设值的设置,可以根据粒子正常荧光强度情况下的正常红细胞参数值作为参考。Step 350 performing increasing correction on the fluorescent signal information according to the red blood cell parameter includes: performing increasing correction on the fluorescent signal information if the red blood cell parameter is greater than a first preset value. Further, in one embodiment, if the red blood cell parameter is greater than the first preset value, the larger the red blood cell parameter is, the larger the magnitude of the increase correction performed on the fluorescent signal information in
如上所述,红细胞参数可以包RBC、HGB和HCT中的至少一种。当红细胞参数只包括RBC、HGB和HCT中的一种时,那么红细胞参数大于第一预设值很好理解;当红细胞参数包括RBC、HGB和HCT中的二种或三种时,红细胞参数大于第一预设值可以指的是:将红细胞参数所包括的RBC、HGB和HCT中的二种或三种进行加权和,或者加权平均计算,具体的权重值可以在实际中灵活设置,计算得到的值作为红细胞参数来与第一预设值比较,当计算得到的值大于第一预设值时,就认为是红细胞参数大于第一预设值。例如,当红细胞参数包括RBC、HGB和HCT这三种时,计算RBC、HGB和HCT这三个参数进行加权和,或者加权平均计算,将计算得到的值视为红细胞参数的值来与第一预设值进行比较,当计算得到的值大于第一预设值,就表示红细胞参数大于第一预设值。As mentioned above, the red blood cell parameters may include at least one of RBC, HGB and HCT. When the red blood cell parameters only include one of RBC, HGB and HCT, it is well understood that the red blood cell parameters are greater than the first preset value; when the red blood cell parameters include two or three of RBC, HGB and HCT, the red blood cell parameters are greater than The first preset value may refer to: performing a weighted sum of two or three of RBC, HGB, and HCT included in the red blood cell parameters, or a weighted average calculation. The specific weight value can be flexibly set in practice, and the calculated The value of is used as the red blood cell parameter to compare with the first preset value, and when the calculated value is greater than the first preset value, it is considered that the red blood cell parameter is greater than the first preset value. For example, when the red blood cell parameters include RBC, HGB and HCT, the weighted sum of the three parameters of RBC, HGB and HCT is calculated, or the weighted average is calculated, and the calculated value is regarded as the value of the red blood cell parameter to be compared with the first The preset value is compared, and when the calculated value is greater than the first preset value, it means that the red blood cell parameter is greater than the first preset value.
(2)减少修正(2) Reduce correction
步骤350根据所述红细胞参数对所述荧光信号信息进行减少修正,包括:如果所述红细胞参数小于第一预设值,则对所述荧光信号信息进行减少修正。进一步地,在一实施例中如果所述红细胞参数小于第一预设值,则所述红细胞参数越小,步骤350对所述荧光信号信息进行减少修正的幅度越大Step 350 performing reduction correction on the fluorescent signal information according to the red blood cell parameter includes: performing reduction correction on the fluorescent signal information if the red blood cell parameter is smaller than a first preset value. Further, in one embodiment, if the red blood cell parameter is smaller than the first preset value, the smaller the red blood cell parameter is, the larger the reduction and correction of the fluorescent signal information in
如上所述,红细胞参数可以包RBC、HGB和HCT中的至少一种。当红细胞参数只包括RBC、HGB和HCT中的一种时,那么红细胞参数小于第一预设值很好理解;当红细胞参数包括RBC、HGB和HCT中的二种或三种时,红细胞参数小于第一预设值可以指的是:将红细胞参数所包括的RBC、HGB和HCT中的二种或三种进行加权和,或者加权平均计算,具体的权重值可以在实际中灵活设置,计算得到的值作为红细胞参数来与第一预设值比较,当计算得到的值小于第一预设值时,就认为是红细胞参数小于第一预设值。例如,当红细胞参数包括RBC、HGB和HCT这三种时,计算RBC、HGB和HCT这三个参数进行加权和,或者加权平均计算,将计算得到的值视为红细胞参数的值来与第一预设值进行比较,当计算得到的值小于第一预设值,就表示红细胞参数小于第一预设值。As mentioned above, the red blood cell parameters may include at least one of RBC, HGB and HCT. When the red blood cell parameters include only one of RBC, HGB and HCT, it is easy to understand that the red blood cell parameters are less than the first preset value; when the red blood cell parameters include two or three of RBC, HGB and HCT, the red blood cell parameters are less than The first preset value may refer to: performing a weighted sum of two or three of RBC, HGB, and HCT included in the red blood cell parameters, or a weighted average calculation. The specific weight value can be flexibly set in practice, and the calculated The value of is used as the red blood cell parameter to compare with the first preset value, and when the calculated value is smaller than the first preset value, it is considered that the red blood cell parameter is smaller than the first preset value. For example, when the red blood cell parameters include RBC, HGB and HCT, the weighted sum of the three parameters of RBC, HGB and HCT is calculated, or the weighted average is calculated, and the calculated value is regarded as the value of the red blood cell parameter to be compared with the first Compared with the preset value, when the calculated value is smaller than the first preset value, it means that the red blood cell parameter is smaller than the first preset value.
步骤350根据所述红细胞参数对所述荧光信号信息进行增大修正和/或减少修正,包括:将所述红细胞参数和所述荧光信号信息作为自变量代入预设的修正函数,以得到修正后的荧光信号信息,其中所述修正函数为增函数。在一实施例中,所述修正函数为为一次函数或幂函数。在一实施例中,所述修正函数包括第一函数和第二函数,所述第一函数和第二函数均为增函数;所述处理器将所述红细胞参数和所述荧光信号信息作为自变量代入预设的修正函数包括:将所述红细胞参数作为自变量代入所述第一函数得到修正系数,将所述修正系数作为常量和将所述荧光信号信息作为自变量代入所述第二函数以得到修正后的荧光信号信息。在一实施例中,所述第一函数和第二函数均为一次函数。关于修正函数、第一函数和第二函数的举例可以参考实施例1,在以下的实施例中也将会举例详述,在此不再赘述。Step 350 performs increase correction and/or decrease correction on the fluorescent signal information according to the red blood cell parameters, including: substituting the red blood cell parameters and the fluorescent signal information as independent variables into a preset correction function to obtain the corrected Fluorescent signal information of , wherein the correction function is an increasing function. In one embodiment, the correction function is a linear function or a power function. In one embodiment, the correction function includes a first function and a second function, both of which are increasing functions; the processor uses the red blood cell parameters and the fluorescent signal information as an automatic Substituting variables into the preset correction function includes: substituting the red blood cell parameters as an independent variable into the first function to obtain a correction coefficient, using the correction coefficient as a constant and the fluorescent signal information as an independent variable into the second function In order to obtain the corrected fluorescent signal information. In an embodiment, both the first function and the second function are linear functions. For examples of the correction function, the first function and the second function, reference may be made to
请参照图4,分析方法的一个实施例中还可以包括步骤370:输出经过修正后的荧光信号信息,例如根据修正后的荧光信号信息通过显示器显示荧光信号散点图,或者将修正后的荧光信号信息发送给远端服务器、中央站。Please refer to FIG. 4 , an embodiment of the analysis method may also include step 370: outputting the corrected fluorescence signal information, for example, displaying the fluorescence signal scattergram on the display according to the corrected fluorescence signal information, or displaying the corrected fluorescence signal information The signal information is sent to the remote server and the central station.
当然,在一些实施例中,修正之后,还可以输出经过修正前和修正后的荧光信号信息,例如根据修正后的荧光信号信息通过显示器显示修正后的荧光信号散点图,并根据修正前的荧光信号信息通过显示器显示修正前的荧光信号散点图,以方便用户对比。Certainly, in some embodiments, after correction, the fluorescence signal information before correction and after correction can also be output, for example, displaying the corrected fluorescence signal scatter diagram on the display according to the corrected fluorescence signal information, and displaying the corrected Fluorescent signal information displays the scatter diagram of the fluorescent signal before correction through the monitor, which is convenient for users to compare.
在一些实施例中,修正之后,还可以发出荧光信号信息已经过修正的提示,例如通过显示器向用户发出提示。而在一些实施例中,处理器104还可以输出荧光信号信息的修正幅度,例如通过显示器以百分比的形式显示荧光信号信息的修正幅度。在一些实施例中,修正之后,如果荧光信号信息的修正幅度超过设定的阈值,则才发出荧光信号信息已经过修正的提示或发出报警。In some embodiments, after correction, a reminder that the fluorescent signal information has been corrected may also be issued, for example, a reminder is issued to the user through a display. In some embodiments, the
实施例3Example 3
对应上述的血液样本的荧光信号信息修正方法,本发明一实施例还公开了一种血液样本的荧光信号信息修正装置,请参照图5,该血液样本的荧光信号信息修正装置可以包括存储器210和处理器230,存储器210用于存储程序,处理器230用于通过执行存储器210存储的程序以实现上述任一实施例的分析方法,例如实现上述的步骤300、步骤330和步骤350,还可以用来实现步骤370。处理器230可以和血液细胞分析仪中的处理器104的功能类似或相同。下面具体说明。Corresponding to the above method for correcting fluorescence signal information of blood samples, an embodiment of the present invention also discloses a device for correcting fluorescence signal information of blood samples, please refer to FIG. 5 , the device for correcting fluorescence signal information of blood samples may include a
处理器230的一个实施例中,其获取经荧光试剂处理后的血液样本的荧光信号信息,获取已测量的所述血液样本中的红细胞参数,根据所述红细胞参数对所述荧光信号信息进行修正。荧光信号主要表示白细胞粒子或血影粒子,其中血影粒子是指红细胞经低渗处理后,质膜破裂剩下保持原来的形态和大小的细胞膜结构的粒子。一实施例中,所述红细胞参数包括红细胞压积、红细胞计数和血红蛋白浓度中至少一种。In one embodiment of the
如上所述,处理器230获取的数据有血液样本的荧光信息号信息以及血液样本中的红细胞参数,在一实施例中,处理器230还可以获取所述血液样本的前向散射光信号信息或侧向散射光信号信息。这三类数据——即第一类数据:血液样本的荧光信息号信息,第二类数据:所述血液样本的前向散射光信号信息或侧向散射光信号信息,第三类数据:所述血液样本中的红细胞参数——的一项或多项可以由其他设备传输给处理器230。As mentioned above, the data acquired by the
处理器230根据所述红细胞参数对所述荧光信号信息进行修正,可以包括:根据所述红细胞参数对所述荧光信号信息进行增大修正和/或减少修正。修正的目标是:无论HCT、RBC、HGB这些红细胞参数如何变化,粒子对应的荧光信号值都被修正到粒子的正常荧光信号强度值附近。The
(1)增大修正(1) Increase correction
处理器230根据所述红细胞参数对所述荧光信号信息进行增大修正,包括:如果所述红细胞参数大于第一预设值,则对所述荧光信号信息进行增大修正。进一步地,在一实施例中如果所述红细胞参数大于第一预设值,则所述红细胞参数越大,处理器230对所述荧光信号信息进行增大修正的幅度越大。第一预设值的设置,可以根据粒子正常荧光强度情况下的正常红细胞参数值作为参考。如上所述,红细胞参数可以包RBC、HGB和HCT中的至少一种。当红细胞参数只包括RBC、HGB和HCT中的一种时,那么红细胞参数大于第一预设值很好理解;当红细胞参数包括RBC、HGB和HCT中的二种或三种时,红细胞参数大于第一预设值可以指的是:将红细胞参数所包括的RBC、HGB和HCT中的二种或三种进行加权和,或者加权平均计算,具体的权重值可以在实际中灵活设置,计算得到的值作为红细胞参数来与第一预设值比较,当计算得到的值大于第一预设值时,就认为是红细胞参数大于第一预设值。例如,当红细胞参数包括RBC、HGB和HCT这三种时,计算RBC、HGB和HCT这三个参数进行加权和,或者加权平均计算,将计算得到的值视为红细胞参数的值来与第一预设值进行比较,当计算得到的值大于第一预设值,就表示红细胞参数大于第一预设值。The
(2)减少修正(2) Reduce correction
处理器230根据所述红细胞参数对所述荧光信号信息进行减少修正,包括:如果所述红细胞参数小于第一预设值,则对所述荧光信号信息进行减少修正。进一步地,在一实施例中如果所述红细胞参数小于第一预设值,则所述红细胞参数越小,处理器230对所述荧光信号信息进行减少修正的幅度越大The
如上所述,红细胞参数可以包RBC、HGB和HCT中的至少一种。当红细胞参数只包括RBC、HGB和HCT中的一种时,那么红细胞参数小于第一预设值很好理解;当红细胞参数包括RBC、HGB和HCT中的二种或三种时,红细胞参数小于第一预设值可以指的是:将红细胞参数所包括的RBC、HGB和HCT中的二种或三种进行加权和,或者加权平均计算,具体的权重值可以在实际中灵活设置,计算得到的值作为红细胞参数来与第一预设值比较,当计算得到的值小于第一预设值时,就认为是红细胞参数小于第一预设值。例如,当红细胞参数包括RBC、HGB和HCT这三种时,计算RBC、HGB和HCT这三个参数进行加权和,或者加权平均计算,将计算得到的值视为红细胞参数的值来与第一预设值进行比较,当计算得到的值小于第一预设值,就表示红细胞参数小于第一预设值。As mentioned above, the red blood cell parameters may include at least one of RBC, HGB and HCT. When the red blood cell parameters include only one of RBC, HGB and HCT, it is easy to understand that the red blood cell parameters are less than the first preset value; when the red blood cell parameters include two or three of RBC, HGB and HCT, the red blood cell parameters are less than The first preset value may refer to: performing a weighted sum of two or three of RBC, HGB, and HCT included in the red blood cell parameters, or a weighted average calculation. The specific weight value can be flexibly set in practice, and the calculated The value of is used as the red blood cell parameter to compare with the first preset value, and when the calculated value is smaller than the first preset value, it is considered that the red blood cell parameter is smaller than the first preset value. For example, when the red blood cell parameters include RBC, HGB and HCT, the weighted sum of the three parameters of RBC, HGB and HCT is calculated, or the weighted average is calculated, and the calculated value is regarded as the value of the red blood cell parameter to be compared with the first Compared with the preset value, when the calculated value is smaller than the first preset value, it means that the red blood cell parameter is smaller than the first preset value.
处理器230根据所述红细胞参数对所述荧光信号信息进行增大修正和/或减少修正,包括:将所述红细胞参数和所述荧光信号信息作为自变量代入预设的修正函数,以得到修正后的荧光信号信息,其中所述修正函数为增函数。在一实施例中,所述修正函数可以为一次函数或幂函数。在一实施例中,所述修正函数包括第一函数和第二函数,所述第一函数和第二函数均为增函数;所述处理器将所述红细胞参数和所述荧光信号信息作为自变量代入预设的修正函数包括:将所述红细胞参数作为自变量代入所述第一函数得到修正系数,将所述修正系数作为常量和将所述荧光信号信息作为自变量代入所述第二函数以得到修正后的荧光信号信息。在一实施例中,所述第一函数和第二函数均为一次函数。关于修正函数、第一函数和第二函数的举例可以参考实施例1,或者参考下面将会详述的具体实施例,在此不再赘述。The
处理器230的一个实施例中,还可以输出经过修正后的荧光信号信息,例如根据修正后的荧光信号信息通过显示器显示荧光信号散点图,或者将修正后的荧光信号信息发送给远端服务器、中央站。In an embodiment of the
当然,在一些实施例中,修正之后,处理器230还可以输出经过修正前和修正后的荧光信号信息,例如根据修正后的荧光信号信息通过显示器显示修正后的荧光信号散点图,并根据修正前的荧光信号信息通过显示器显示修正前的荧光信号散点图,以方便用户对比。Of course, in some embodiments, after the correction, the
在一些实施例中,修正之后,处理器230还可以发出荧光信号信息已经过修正的提示,例如通过显示器向用户发出提示。而在一些实施例中,处理器104还可以输出荧光信号信息的修正幅度,例如通过显示器以百分比的形式显示荧光信号信息的修正幅度。在一些实施例中,修正之后,如果荧光信号信息的修正幅度超过设定的阈值,则才发出荧光信号信息已经过修正的提示或发出报警。In some embodiments, after correction, the
本发明对荧光信号信息的修正依赖于红细胞参数,例如HCT、RBC和HGB的一个或多个。在血液细胞的分析中HCT、RBC和HGB等红细胞参数为常规测量参数,因此可以在不增加试剂耗量、不增加测量通道的情况下,完成对荧光信号信息的修正,这样测量成本并不会增加,同时又提高了需要荧光信号信息的测量通道——例如NRBC通道、RET通道和DIFF通道等的测量结果的准确性,例如可以更加准确地给出WBC计数、NRBC分类、Baso分类等结果。The correction of fluorescent signal information by the present invention depends on red blood cell parameters, such as one or more of HCT, RBC and HGB. In the analysis of blood cells, red blood cell parameters such as HCT, RBC, and HGB are routinely measured parameters, so the correction of fluorescent signal information can be completed without increasing reagent consumption and measuring channels, so that the measurement cost will not Increase, and at the same time improve the accuracy of measurement results of measurement channels that require fluorescent signal information—such as NRBC channels, RET channels, and DIFF channels. For example, WBC counts, NRBC classification, Baso classification and other results can be given more accurately.
下面以实例的例子来说明本发明如何根据所述红细胞参数对所述荧光信号信息进行修正。The following examples illustrate how the present invention corrects the fluorescent signal information according to the red blood cell parameters.
以下在说明荧光信号信息与红细胞参数之间的关系的时候,主要是研究实验中WBC粒子团的荧光信号与红细胞参数之间的关系。申请人统计了482例样本,以这些样本的HCT、RBC、HGB为横轴,以WBC粒子团在荧光方向上的位置为纵轴,绘制了散点图,如图6、图7和图8所示。In the following, when explaining the relationship between the fluorescent signal information and the red blood cell parameters, it is mainly to study the relationship between the fluorescent signal of the WBC particle cluster and the red blood cell parameters in the experiment. The applicant counted 482 samples, took the HCT, RBC, and HGB of these samples as the horizontal axis, and took the position of the WBC particle cluster in the fluorescence direction as the vertical axis to draw a scatter diagram, as shown in Figure 6, Figure 7 and Figure 8 shown.
从图6至图8的散点图可以看出,WBC粒子团在荧光方向上的位置值与HCT、RBC、HGB呈负相关的关系,即HCT、RBC、HGB越小,WBC粒子团在荧光方向上的位置值越大;HCT、RBC、HGB越大,WBC粒子团在荧光方向上的位置值越小。From the scatter plots in Figure 6 to Figure 8, it can be seen that the position value of WBC particle clusters in the fluorescence direction is negatively correlated with HCT, RBC, and HGB, that is, the smaller the HCT, RBC, and HGB, the smaller the WBC particle clusters are in the fluorescence direction. The larger the position value in the direction; the larger the HCT, RBC, and HGB, the smaller the position value of the WBC particle group in the fluorescence direction.
可以使用HCT、RBC和HGB中的一个或多个来计算出一个修正系数,然后使用该计算出来的修正系数对荧光信号信息进行修正,例如将该修正系数乘以荧光信号信息来得到修正后的荧光信号信息。以图6至图8为例,修正的目标是使得WBC粒子团在荧光方向上的位置值随着HCT、RBC、HGB这些参数的变化基本不变。在图6至图8中,我们可以将WBC粒子团在荧光方向上的位置值等于2000定为目标水平线(即白细胞粒子团的正常荧光信号强度值,数值依据不同的系统而不同),即无论HCT、RBC、HGB这些参数如何变化,WBC粒子团在荧光方向上的位置值基本维持在2000附近。随着HCT、RBC、HGB参数的变化,粒子对应的荧光信号值都被修正到粒子的正常荧光信号强度值附近。图6中,HCT对应的第一预设值在29附近;图7中,RBC对应的第一预设值在2.3附近;图8中,HGB对应的第一预设值在85附近。第一预设值的设置,可以根据粒子正常荧光强度情况下的正常红细胞参数值作为参考,可以理解为修正系数为1时所对应的红细胞参数值。One or more of HCT, RBC and HGB can be used to calculate a correction coefficient, and then use the calculated correction coefficient to correct the fluorescence signal information, for example multiply the correction coefficient by the fluorescence signal information to obtain the corrected Fluorescent signal information. Taking Fig. 6 to Fig. 8 as an example, the goal of the correction is to make the position value of the WBC cluster in the direction of fluorescence basically unchanged with the changes of parameters such as HCT, RBC, and HGB. In Figures 6 to 8, we can set the position value of the WBC particle cluster in the fluorescence direction equal to 2000 as the target horizontal line (that is, the normal fluorescence signal intensity value of the white blood cell cluster, and the value varies according to different systems), that is, no matter How do the parameters of HCT, RBC, and HGB change, and the position value of the WBC particle group in the direction of fluorescence is basically maintained around 2000. With the change of HCT, RBC, HGB parameters, the fluorescence signal value corresponding to the particle is corrected to be close to the normal fluorescence signal intensity value of the particle. In Figure 6, the first preset value corresponding to HCT is around 29; in Figure 7, the first preset value corresponding to RBC is around 2.3; in Figure 8, the first preset value corresponding to HGB is around 85. The setting of the first preset value can be based on the normal erythrocyte parameter value under the condition of normal fluorescence intensity of the particle as a reference, which can be understood as the corresponding erythrocyte parameter value when the correction coefficient is 1.
不妨以根据HCT修正NRBC通中的荧光信号信息为例,根据上述图6的拟合结果,申请人构建了第一函数f11(x1)=0.038x1+0.09,其中x1表示HCT的值,将HCT的值代入可计算得到修正系数;如图9所示为第一函数的函数图,横坐标为HCT的值,纵坐标为修正系数的值,可以看到HCT越大,修正系数越大,即第一函数为增函数。计算得到修正系数后,再将荧光信息信号乘以该修正系数,即得到修正后的荧光信号信息,例如第二函数f12(xfl)=k1xfl+b,其中k1=f11(x1)=0.038x1+0.09,xfl表示修正前的荧光信号信息;因此修正函数为:Let’s take HCT as an example to correct the fluorescent signal information in NRBC. According to the fitting results in Figure 6 above, the applicant constructed the first function f 11 (x 1 )=0.038x 1 +0.09, where x 1 represents the HCT value, the correction coefficient can be calculated by substituting the value of HCT; as shown in Figure 9, the function diagram of the first function, the abscissa is the value of HCT, and the ordinate is the value of the correction coefficient. It can be seen that the larger the HCT, the larger the correction coefficient The larger it is, the first function is an increasing function. After calculating the correction coefficient, multiply the fluorescence information signal by the correction coefficient to obtain the corrected fluorescence signal information, for example, the second function f 12 (x fl )=k 1 x fl +b, where k 1 =f 11 (x 1 )=0.038x 1 +0.09, x fl represents the fluorescent signal information before correction; therefore the correction function is:
yfl=f1(x1,xfl)=(0.038x1+0.09)*xfl+b;y fl =f 1 (x 1 ,x fl )=(0.038x 1 +0.09)*x fl +b;
其中yfl表示修正后的荧光信号信息;b为常数,例如为0;符号*为乘号。Wherein y fl represents the corrected fluorescent signal information; b is a constant, for example, 0; the symbol * is a multiplication sign.
用于修正的第一函数可以对应为一次函数,也可以对应为其他的函数形式,例如幂函数。总之,修正目标都是无论HCT、RBC、HGB这些参数如何变化,WBC粒子团在荧光方向上的位置值基本维持在目标线附近,粒子对应的荧光信号值都被修正到粒子的正常荧光信号强度值附近。The first function used for correction may correspond to a linear function, or may correspond to other functional forms, such as a power function. In short, the correction target is no matter how the parameters of HCT, RBC, and HGB change, the position value of the WBC particle cluster in the fluorescence direction is basically maintained near the target line, and the fluorescence signal value corresponding to the particle is corrected to the normal fluorescence signal intensity of the particle. near the value.
如图10中显示了NRBC通道中三个样本的细胞粒子(主要是右上角的WBC粒子团和左下角的血影粒子团)的散点图,其中横坐标为细胞粒子的荧光信号信息的值,纵坐标为细胞粒子的前向散色光信号信息。下面根据上述的修正函数yfl=f1(x1,xfl)=(0.038x1+0.09)*xfl+b分别对样本1、样本2和样本3进行荧光信号信息的修正,其中b取为0。Figure 10 shows the scatter diagram of the cell particles of the three samples in the NRBC channel (mainly the WBC particle cluster in the upper right corner and the ghost particle cluster in the lower left corner), where the abscissa is the value of the fluorescence signal information of the cell particles , and the ordinate is the forward scatter light signal information of the cell particle. Next, according to the above-mentioned correction function y fl =f 1 (x 1 ,x fl )=(0.038x 1 +0.09)*x fl +b, the fluorescence signal information of
样本1中RBC=0.76×10.^12/L,HGB=26g/L,HCT=8.2%。如图10(a)为NRBC通道中所获取的未修正前的细胞粒子的散点图,可以看到细胞粒子团的荧光信号信息偏大;样本1的HCT值为8.2%,带入第一函数f11(x1)=0.038x1+0.09后得出修正系数为0.4016。将此修正系数0.4016乘以样本1的各细胞粒子的荧光信号信息的值,可以得到修正后的各细胞粒子的荧光信号信息的值,如图10(d)。In
样本2中RBC=3.25×10.^12/L,HGB=71g/L,HCT=23.8%。如图10(b)为NRBC通道中所获取的未修正前的细胞粒子的散点图,可以看到WBC粒子团的荧光信号信息适中;样本2的HCT值为23.8%,带入第一函数f11(x1)=0.038x1+0.09后得出修正系数为0.9944。将此修正系数0.9944乘以样本2的各细胞粒子的荧光信号信息的值,可以得到修正后的各细胞粒子的荧光信号信息的值,如图10(e)。In
样本3中RBC=7.04×10.^12/L,HGB=158g/L,HCT=50.3%。如图10(c)为NRBC通道中所获取的未修正前的细胞粒子的散点图,可以看到细胞粒子团的荧光信号信息偏小;样本3的HCT值为50.3%,带入第一函数f11(x1)=0.038x1+0.09后得出修正系数为2.0014。将此修正系数2.0014乘以样本3的各细胞粒子的荧光信号信息的值,可以得到修正后的各细胞粒子的荧光信号信息的值,如图10(f)。In
从图10(e)~10(f)可以看出,细胞粒子团的荧光信号都修正到较合适的范围,即在散点图中相对偏中的位置。From Figures 10(e) to 10(f), it can be seen that the fluorescent signals of the cell particle clusters are all corrected to a more appropriate range, that is, a relatively central position in the scatter diagram.
由于NRBC通道、BASO通道、RET通道、DIFF通道等通道染料法存在染料竞争导致白细胞群的荧光信号不正常的问题,容易导致白细胞群或NRBC群分类出错。在白细胞分类中,申请人通过长期研发发现,在一些样本下,当使用荧光染料处理细胞,利用荧光信号和散射光信号对细胞进行分类时,会出现测量结果与镜检的结果有偏差的情况。通过深入的研究发现,这类样本中,红细胞的参数与正常值不同。通过验证发现,红细胞参数与荧光信号强度存在一定的相关性,可以利用红细胞参数来修正荧光信号。虽然不受理论约束,本申请人推测可能红细胞会影响其他需要分类细胞的染色行为,导致荧光信号异常。Due to the dye competition of NRBC channel, BASO channel, RET channel, DIFF channel and other channel dye methods, the fluorescent signal of white blood cell population is abnormal, which may easily lead to errors in the classification of white blood cell population or NRBC population. In the classification of white blood cells, the applicant has discovered through long-term research and development that, in some samples, when the cells are treated with fluorescent dyes and the cells are classified using fluorescent signals and scattered light signals, there will be deviations between the measurement results and the results of microscopic examination . Through in-depth research, it was found that in such samples, the parameters of red blood cells were different from normal values. Through verification, it is found that there is a certain correlation between the red blood cell parameters and the intensity of the fluorescent signal, and the red blood cell parameters can be used to correct the fluorescent signal. While not being bound by theory, the applicant speculates that red blood cells may affect the staining behavior of other cells that need to be sorted, resulting in abnormal fluorescent signals.
本申请的实施例根据红细胞参数对荧光信号进行修正,从而修正白细胞群在散点图的位置,解决白细胞群划分不准确的问题。在白细胞分类中,以固定划界算法为例,本申请的实施例可以让目标粒子群,例如白细胞群,或有核红细胞群,或者网织红细胞群,能准确地处于固定划界算法之预设的区域中,保证分类和计数的准确性。本申请可以在NRBC通道、BASO通道、WNB通道、RET通道、DIFF通道下,用红细胞参数校正荧光信号从而校正白细胞群在散点图的位置。The embodiment of the present application corrects the fluorescent signal according to the red blood cell parameters, thereby correcting the position of the white blood cell group in the scatter diagram, and solving the problem of inaccurate classification of the white blood cell group. In white blood cell classification, taking the fixed demarcation algorithm as an example, the embodiment of the present application can allow the target particle group, such as white blood cell group, or nucleated red blood cell group, or reticulocyte group, to be accurately located in the predetermined area of the fixed demarcation algorithm. In the designated area, the accuracy of classification and counting is guaranteed. This application can correct the fluorescent signal with red blood cell parameters under the NRBC channel, BASO channel, WNB channel, RET channel, and DIFF channel, so as to correct the position of the white blood cell group in the scatter diagram.
本领域技术人员可以理解,上述实施方式中各种方法的全部或部分功能可以通过硬件的方式实现,也可以通过计算机程序的方式实现。当上述实施方式中全部或部分功能通过计算机程序的方式实现时,该程序可以存储于一计算机可读存储介质中,存储介质可以包括:只读存储器、随机存储器、磁盘、光盘、硬盘等,通过计算机执行该程序以实现上述功能。例如,将程序存储在设备的存储器中,当通过处理器执行存储器中程序,即可实现上述全部或部分功能。另外,当上述实施方式中全部或部分功能通过计算机程序的方式实现时,该程序也可以存储在服务器、另一计算机、磁盘、光盘、闪存盘或移动硬盘等存储介质中,通过下载或复制保存到本地设备的存储器中,或对本地设备的系统进行版本更新,当通过处理器执行存储器中的程序时,即可实现上述实施方式中全部或部分功能。Those skilled in the art can understand that all or part of the functions of the various methods in the foregoing implementation manners can be realized by means of hardware, or by means of computer programs. When all or part of the functions in the above embodiments are implemented by means of a computer program, the program can be stored in a computer-readable storage medium, and the storage medium can include: read-only memory, random access memory, magnetic disk, optical disk, hard disk, etc., through The computer executes the program to realize the above-mentioned functions. For example, the program is stored in the memory of the device, and when the processor executes the program in the memory, all or part of the above-mentioned functions can be realized. In addition, when all or part of the functions in the above embodiments are realized by means of a computer program, the program can also be stored in a storage medium such as a server, another computer, a magnetic disk, an optical disk, a flash disk, or a mobile hard disk, and saved by downloading or copying. To the memory of the local device, or to update the version of the system of the local device, when the processor executes the program in the memory, all or part of the functions in the above embodiments can be realized.
以上应用了具体个例对本发明进行阐述,只是用于帮助理解本发明,并不用以限制本发明。对于本发明所属技术领域的技术人员,依据本发明的思想,还可以做出若干简单推演、变形或替换。The above uses specific examples to illustrate the present invention, which is only used to help understand the present invention, and is not intended to limit the present invention. For those skilled in the technical field to which the present invention belongs, some simple deduction, deformation or replacement can also be made according to the idea of the present invention.
Claims (29)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811045480.8A CN110887818B (en) | 2018-09-07 | 2018-09-07 | Analysis method of blood sample, blood cell analyzer and storage medium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811045480.8A CN110887818B (en) | 2018-09-07 | 2018-09-07 | Analysis method of blood sample, blood cell analyzer and storage medium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110887818A CN110887818A (en) | 2020-03-17 |
| CN110887818B true CN110887818B (en) | 2023-05-02 |
Family
ID=69744710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811045480.8A Active CN110887818B (en) | 2018-09-07 | 2018-09-07 | Analysis method of blood sample, blood cell analyzer and storage medium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110887818B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021207894A1 (en) * | 2020-04-13 | 2021-10-21 | 深圳迈瑞生物医疗电子股份有限公司 | Cell analysis method, cell analyzer and computer-readable storage medium |
| EP3905260A1 (en) * | 2020-04-28 | 2021-11-03 | Sysmex Corporation | Method, apparatus and system for testing blood |
| CN111812012B (en) * | 2020-06-29 | 2023-08-11 | 迈克医疗电子有限公司 | Method and device for identifying nucleated red blood cell area and blood analyzer |
| CN114062663B (en) * | 2020-08-04 | 2025-12-19 | 深圳迈瑞生物医疗电子股份有限公司 | Sample analyzer, signal acquisition method and computer storage medium |
| CN114324921A (en) * | 2020-09-30 | 2022-04-12 | 深圳迈瑞生物医疗电子股份有限公司 | Sample analyzer, sample analysis method and animal blood sample analyzer |
| CN112730203B (en) * | 2020-12-29 | 2023-06-16 | 深圳市科曼医疗设备有限公司 | Optical system, optical gain calibration method, and storage medium for blood cell analyzer |
| CN114965230A (en) * | 2022-05-19 | 2022-08-30 | 桂林优利特医疗电子有限公司 | Flow type fluorescence counting and correcting method |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102109430A (en) * | 2009-12-25 | 2011-06-29 | 深圳迈瑞生物医疗电子股份有限公司 | Nucleated red blood cell simulation particle and blood quality control substance and preparation methods and application thereof |
| CN103975054A (en) * | 2011-05-04 | 2014-08-06 | 雅培制药有限公司 | Nucleated red blood cell analysis system and method |
| CN104515728A (en) * | 2013-09-30 | 2015-04-15 | 深圳迈瑞生物医疗电子股份有限公司 | Blood cell analyzer, reticulocyte counting apparatus and count correcting method |
| CN107202903A (en) * | 2016-03-18 | 2017-09-26 | 深圳迈瑞生物医疗电子股份有限公司 | Sample analyzer and sample analysis method thereof |
| CN107427247A (en) * | 2014-10-09 | 2017-12-01 | 诺瓦达克技术公司 | Use quantifying for the absolute blood flow in the tissue of the photoplethysmography of fluorescence mediation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4745030B2 (en) * | 2005-11-15 | 2011-08-10 | シスメックス株式会社 | Blood analyzer |
-
2018
- 2018-09-07 CN CN201811045480.8A patent/CN110887818B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102109430A (en) * | 2009-12-25 | 2011-06-29 | 深圳迈瑞生物医疗电子股份有限公司 | Nucleated red blood cell simulation particle and blood quality control substance and preparation methods and application thereof |
| CN103975054A (en) * | 2011-05-04 | 2014-08-06 | 雅培制药有限公司 | Nucleated red blood cell analysis system and method |
| CN104515728A (en) * | 2013-09-30 | 2015-04-15 | 深圳迈瑞生物医疗电子股份有限公司 | Blood cell analyzer, reticulocyte counting apparatus and count correcting method |
| CN107427247A (en) * | 2014-10-09 | 2017-12-01 | 诺瓦达克技术公司 | Use quantifying for the absolute blood flow in the tissue of the photoplethysmography of fluorescence mediation |
| CN107202903A (en) * | 2016-03-18 | 2017-09-26 | 深圳迈瑞生物医疗电子股份有限公司 | Sample analyzer and sample analysis method thereof |
Non-Patent Citations (2)
| Title |
|---|
| Sysmex XE-5000血细胞分析仪各新参数在血液学检验中的应用;杨学敏等;《国际检验医学杂志》;20111030(第17期);全文 * |
| 胸腹水高荧光细胞筛查恶性积液价值研究;左路广等;《医疗卫生装备》;20150915(第09期);全文 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110887818A (en) | 2020-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110887818B (en) | Analysis method of blood sample, blood cell analyzer and storage medium | |
| US11726031B2 (en) | Fluorescent spectrum correcting method and fluorescent spectrum measuring device | |
| JP5636381B2 (en) | Device-to-device method and system for cell population identification | |
| CN112424582B (en) | Method for detecting blood sample, blood sample detector and storage medium | |
| EP2531832B1 (en) | Particle processing systems and methods for normalization/calibration of same | |
| JP5557842B2 (en) | Simultaneous detection and processing in particle analysis | |
| CN103597349B (en) | Identify and count early stage granulocyte (EGC) | |
| CN106662572B (en) | Cell analyzer, particle classification method and device | |
| US20140172321A1 (en) | Leukemia classification using cpd data | |
| CN104515728B (en) | Blood cell analyzer, reticulocyte counting device and counting correction method | |
| WO2020113527A1 (en) | Method for detecting white blood cells, blood cell analyzer, and storage medium | |
| US9719123B2 (en) | Urine sample analyzer and urine sample analyzing method | |
| CN112730203A (en) | Optical system of blood cell analyzer, optical gain calibration method and storage medium | |
| CN105986003B (en) | White blood cell counting method and device and cell analyzer | |
| US11193927B2 (en) | Automated body fluid analysis | |
| CN113227757B (en) | A blood cell parameter correction method, blood sample detector and storage medium | |
| CN107817208A (en) | A kind of hemocytometer counting apparatus and its white blood cell count(WBC) modification method | |
| EP4010682B1 (en) | Detecting and reporting subpopulations of neutrophils | |
| CN111812068A (en) | Method and device for determining abnormal lymphocyte and cell analyzer | |
| WO2025240490A1 (en) | Detection of bacteremia using hematology parameters | |
| AU2025214520A1 (en) | Fluorescence sensitivity monitor for a flow cytometer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |